VOYA Investment Management’s Dianthus Therapeutics DNTH Stock Holding History

VOYA Investment Management’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$883K	Buy	9,061 +2,984	+49%	+$261K	﹤0.01%	1563
2026 Q1	$510K	Buy	+6,077	New	+$352K	﹤0.01%	1709
2024 Q4	–	Sell	-7,961	Closed	-$218K	–	2744
2024 Q3	$218K	Sell	7,961 -155	-2%	-$4.32K	﹤0.01%	2440
2024 Q2	$210K	Buy	+8,116	New	+$195K	﹤0.01%	2441
2022 Q2	–	Sell	-743	Closed	-$34K	–	2805
2022 Q1	$34K	Hold	743	–	–	﹤0.01%	2625
2021 Q4	$53K	Sell	743 -32	-4%	-$3.22K	﹤0.01%	2740
2021 Q3	$90K	Hold	775	–	–	﹤0.01%	2757
2021 Q2	$121K	Buy	775 +145	+23%	+$26.6K	﹤0.01%	2740
2021 Q1	$119K	Hold	630	–	–	﹤0.01%	2647
2020 Q4	$79K	Buy	+630	New	+$71.4K	﹤0.01%	2601
2018 Q4	–	Sell	-15,550	Closed	-$2.99M	–	2562
2018 Q3	$2.99M	Sell	15,550 -134	-0.9%	-$28.2K	0.01%	962
2018 Q2	$3.39M	Buy	+15,684	New	+$3.54M	0.01%	918

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

VOYA Investment Management's DNTH Position: Q2 2026 in Review

VOYA Investment Management increased its Dianthus Therapeutics (DNTH) stake by 49% in Q2 2026, buying an estimated $261K and bringing the position to 9,061 shares worth $883K. The position accounts for ﹤0.01% of the portfolio, ranked #1563.

VOYA Investment Management first reported a position in DNTH in Q2 2018 and has held it in 12 quarters since. The position peaked at $3.39M in Q2 2018. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

VOYA Investment Management held 9,061 shares of Dianthus Therapeutics worth $883K as of Q2 2026.
VOYA Investment Management bought 2,984 Dianthus Therapeutics shares in Q2 2026, an estimated $261K.
Dianthus Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1563 holding.
VOYA Investment Management first reported a position in Dianthus Therapeutics in Q2 2018 and has held it in 12 quarters since.
VOYA Investment Management's Dianthus Therapeutics position peaked at $3.39M in Q2 2018.
270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.